Mikio Kabaki

This inventor holds 5 USPTO granted patents, plus 2 CIPO patents. Top assignees: Shionogi Company Limited, Astrazeneca Ab. Active years: 2000-2011.

USPTO Granted Patents = 5

% Patents Active = 80.0

CIPO Patents = 2

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 45(Granted Patents)

Location History:

Ashiya, JP (2000)
Amagasaki, JP (2004 - 2005)
Hyogo, JP (2011)

Company Filing History:

4 out of 1,001

Shionogi Company Limited

where one patent can have more than one assignee

Years Active: 2000-2011

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8017793 - Oxidation of alcohol with use of hydrogen peroxide and tungsten catalyst (2011-09-13),

2. 6844437 - Process for the production of tert-butyl (E)-(6-[2-[4-(4-flurophenyl)-6-isopropyl-2-[methyl(methylsufonyl)amino]pyrimidin-5-yl]vinyl]4R,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate (2005-01-18),

3. 6784171 - Process for the production of tert-butyl (E)-(6-[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl](4R,6S)-2, 2-dimethyl[1, 3]dioxan-4-yl)acetate (2004-08-31),

4. 6057448 - Process for producing imidazole derivatives (2000-05-02),

5. 6015921 - Process for producing carbamoylmethylurea derivatives (2000-01-18),

Title: Mikio Kabaki: Innovator in Pharmaceutical Chemistry

Introduction

Mikio Kabaki is a notable inventor based in Amagasaki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work primarily focuses on innovative methods for chemical processes that have applications in drug manufacturing.

Latest Patents

Among his latest patents is a method for the oxidation of alcohol using hydrogen peroxide and a tungsten catalyst. This method involves oxidizing an alcohol in an amide solvent with a mixed reagent, showcasing his expertise in chemical reactions. Another significant patent details a process for producing tert-butyl (E)-(6-[2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl]-(4R,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate. This invention not only describes the manufacturing process but also introduces a novel starting material used in the production of pharmaceuticals.

Career Highlights

Mikio Kabaki has worked with prominent companies in the pharmaceutical industry, including Shionogi Company Limited and AstraZeneca. His experience in these organizations has allowed him to develop and refine his innovative approaches to chemical processes.

Collaborations

Throughout his career, Kabaki has collaborated with esteemed colleagues such as Haruo Koike and Louis J. Diorazio. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Mikio Kabaki's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of new pharmaceutical processes and products.